Bone Mineral Density and Risk of Osteoporotic Fractures in Women with Parkinson’s Disease

Table 2

Parameters of 10-year probability of osteoporotic fractures in subjects depending on presence of Parkinson’s disease (Me [25Q–75Q]), %.

Index/group	Group I	Group II	Z
FRAX-MOF^1	4.1 [3.4–5.4]	5.1 [3.6–8.1]	2.3	<0.01
FRAX-HF^1	0.9 [0.6–1.5]	1.6 [0.5–2.4]	2.2	<0.01
FRAX-MOF^2	3.8 [3.3–5.4]	5.2 [3.9–9.8]	4.1	<0.001
FRAX-HF^2	0.6 [0.4–1.2]	1.3 [0.6–3.5]	4.0	<0.001
FRAX-MOF^3	4.1 [3.4–5.4]	7.4 [4.9–11.0]	6.0	<0.001
FRAX-HF^3	0.9 [0.6–1.5]	2.8 [0.9–4.3]	5.0	<0.001

Group I: control group; Group II: females with Parkinson’s disease. ¹Calculated with body mass index. ²Calculated with BMD. ³Calculated without BMD and including PD as a reason of secondary osteoporosis; Z and : differences between the indices in women of both groups (Mann-Whitney U test).